Ocuphire/Opus Merger Creates Public Retinal Gene Therapy Firm

 
• By Joseph Haas
  
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Rare Diseases